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Abstract 
Background: We designed the present study to evaluate the simultaneous effect of obesity in couples on in vitro 
fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes. 
Materials and Methods: In this cross-sectional study, performed at Royan Institute between January 2013 and Janu-
ary 2014, we evaluated the recorded data of all patients during this time period. The study population was limited to 
couples who underwent ICSI or IVF/ICSI cycles with autologous oocytes and fresh embryo transfers. We recorded the 
heights and weights of both genders and divided them into groups according to body mass index (BMI). Multilevel 
logistic regression analysis was used to determine the odds ratio for live births following ICSI or IVF/ICSI.
Results: In total, 990 couples underwent IVF/ICSI cycles during the study period. Among the ovulatory women, a 
significant difference existed between the BMI groups. There was a 60% decrease [95% confidence interval (CI): 
0.11-0.83] in the odds of a live birth among overweight subjects and 84% (95% CI: 0.02-0.99) decrease among obese 
subjects. Among the anovulatory women, the association between the BMI and live births presented no clear tenden-
cies. We did not observe any significant relationship between male BMI and live birth rate. The results demonstrated 
no significant association between the couples’ BMI and live birth rate.
Conclusion: Based on the present findings, increased female BMI independently and negatively influenced birth rates 
after ICSI. However, increased male BMI had no impact on live births after ICSI, either alone or combined with in-
creased female BMI.  
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Introduction 
Obesity is an important risk factor for health problems 
and is deemed to be 1 of the 10 global diseases that con-
tributes to an increased health burden. There is a rapidly 
increasing incidence of this complication in many indus-
trialized countries, particularly the United States, and in 
developing Asian countries (1). 
In numerous studies, researchers evaluated the effects 
of obesity on assisted reproductive technology (ART) cy-
cle outcomes in women (2-13) and reported inconsistent 
results. Koning et al. (14) in a review article, reported that 
there were limited data despite 14 available studies in this 
area and concluded that further studies were needed to 
achieve an accurate insight. 
Currently, there is no evidence to indicate that obesity 
increases the risk for ART complications; however, some 
researchers have reported the negative effects of obesi-
ty on pregnancy rates (14). In contrast, a review article 
published by Rittenberg et al.(15) reported an associa-
tion between obesity and excess weight in women with 
poor pregnancy outcomes. This finding included reduced 
rates for clinical pregnancy and live births. Luke et al. (7) 
concluded that obesity had a negative impact on clinical 
pregnancy and live birth rates along with ART cycles with 
autologous oocytes. They emphasized that this risk could 
be brought under control by the use of donor oocytes.
The mechanism of the effects of female obesity on ART 
outcomes is controversial. The impact of obesity on ART 
outcomes in men is less studied (1, 16, 17) with conflicting 
results. A systemic review and meta-analysis by MacDon-
ald et al. (18) published in 2010, has found no evidence of 
a relationship between increased body mass index (BMI) 
and semen parameters. Thus, further studies would be 
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warranted in this field. Petersen et al. (19) reported that 
maternal and paternal BMI, both independently and com-
bined, exerted negative effects on live birth rates after 
in vitro fertilization (IVF) cycles, but this association in 
intracytoplasmic sperm injection (ICSI) cycles was less 
obvious. In light of the current evidence, we designed the 
present study to assess the impacts of obesity in a couple 
on ART outcomes. This study sought to answer the ques-
tion of whether obesity simultaneously in a couple has a 
negative effect on ICSI cycle outcomes in comparison to 
couples who have normal BMIs. 
Materials and Methods
This was a cross-sectional study performed at Royan 
Institute between January 2013 and January 2014. The 
Review Board and Ethics Committees of Royan Institute 
approved the study protocol. All participating couples 
provided ethical permission at their initial visit for the use 
of their treatment outcomes. Participant confidentiality 
for all participants was assured during the research and 
written informed consent was obtained from them.
Subjects
We evaluated the data recorded during the study period 
from all of the study participants. The study population 
was limited to patients who underwent ICSI or IVF/ICSI 
cycles that resulted in the transfer of 2 or 3 fresh embryos. 
Height and weight were recorded for all couples. Couples 
whose female partner was ≤39 years of age and the male 
partner was <55 years of age (17) at the time of the treat-
ment cycle onset were enrolled to minimize the effect of 
age as a confounding factor. We excluded all cases with 
uterine factor, severe male factor, severe endometriosis, 
and gamete or embryo donor recipients (Fig.1). 
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Fig.1: Sampling procedure and the distribution of the couples according to their BMI. IVF; In vitro fertilization, ICSI; Intra-cytoplasmic sperm injection, BMI; 
Body-mass index, IUI; Intrauterine insemination, PGD; Pre-gestational diagnosis, TESE; Testicular sperm extraction, PESE; Percutaneous epididymal sperm 
extraction, PESA; Percutaneous epididymal sperm aspiration, and TESA; Testicular sperm aspiration.
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The patients’ age (years) was recorded at the begin-
ning of treatment. At the onset of treatment, we clas-
sified participants as smokers or non-smokers accord-
ing to the number of cigarettes smoked per day. The 
diagnosis of infertility was determined according to 
the 10th revision of the International Classification of 
Diseases (11). Accordingly, women participants were 
categorized as ovulatory or an ovulatory. Standard 
ovarian stimulation protocols were performed accord-
ing to routine clinical practice. In brief, suppression 
of the endogenous luteinizing hormone surge was per-
formed with either gonadotropin-releasing hormone 
agonists or antagonists. Controlled ovarian stimulation 
was performed with recombinant follicle-stimulating 
hormone (rFSH) and/or human menopausal gonado-
tropin (hMG); trans-vaginal ultrasound guided ovum 
pickup was performed 34-36 hours after administration 
of human chorionic gonadotropin (hCG). ICSI for re-
trieved MII oocytes, with or without insemination, was 
performed in accordance with standard general recom-
mendations. 
We defined normal fertilization as the appearance of 
the 2nd polar body at 16-19 hours after insemination 
or microinjection. In our institute, embryo quality is 
graded as A, B, C, and D, with "A" defined as the best 
quality and "D", the worst, according to cell numbers, 
percentage of fragmentation, and cell symmetry. All 
embryo transfers were performed with a Labotect cath-
eter (Labotect, Germany) by experienced gynaecolo-
gists and embryologists on day 3 after IVF/ICSI. Lute-
al phase support was provided by administration of 400 
mg of vaginal progesterone twice a day until the day of 
the β-hCG test. Luteal support with progesterone was 
prescribed until the observation of foetal heart activity 
and subsequently tapered until week 8 of gestation. The 
main outcomes were fertilization, implantation, clini-
cal pregnancy, and live birth rates. The implantation 
rate was denoted as the number of visualized intrau-
terine gestational sacs divided by the number of trans-
ferred embryos. A clinical pregnancy was documented 
by ultrasound observation of an intrauterine gestational 
sac with foetal cardiac activity. We defined spontane-
ous abortion as the loss of clinical pregnancy prior to 
20 weeks gestation. Trained nurses routinely measured 
height and weight in participants of both genders prior 
to the onset of the treatment cycle. The balance scale 
for the measurement of weight was calibrated daily 
and verified by a one kg counterweight. We used the 
World Health Organization’s definition of BMI (kg/m2) 
to classify male and female participants as underweight 
(<18.5 kg/m2), normal (18.5-24.9 kg/m2), overweight 
(25-29.9 kg/m2), or obese (≥30 kg/m2) (20). The small 
number of underweight couples precluded their inclu-
sion in the couples’ analysis. We divided the couples 
into 3 groups based on male and female BMI results: 
group 1 (normal weight), group 2 (overweight), and 
group 3 (obese). The main outcomes were compared 
among the three groups. 
Statistical analysis  
Statistical analysis was carried out using the Statis-
tical Package for the Social Sciences (SPSS), version 
20.0 (SPSS Inc., Chicago, IL, USA). The study popula-
tion’s characteristics were compared according to the 
couples’ BMI (normal, overweight, and obese) using 
one-way analysis of variance (ANOVA), Kruskal-
Wallis nonparametric analysis of variance, and the 
chi-square test when appropriate. Multilevel logis-
tic regression analysis was applied to determine the 
odds of live births following ICSI cycles. The analy-
sis was conducted according to the female and male 
BMI groups. Normal-weight patients were considered 
to be the reference group. Analysis of female BMI was 
adjusted for age and duration of infertility. Likewise, 
analysis of the male BMI was adjusted for age, dura-
tion of infertility, and smoking status. 
A multilevel logistic regression analysis was used to 
detect the predictive factors for live births after ICSI 
cycles. All possible factors that affected the live birth 
rate, which included female and male ages, couples’ 
BMI (<25 kg/m2 and ≥25 kg/m2), male smoking sta-
tus, cause and duration of infertility, ovarian stimu-
lation protocol [long gonadotropin-releasing hormone 
(GnRH) agonist and GnRH antagonist protocols], and 
number and quality of transferred embryos were incor-
porated into the model. The results of the multilevel 
logistic regression analysis have been presented as ad-
justed odds ratios (ORs) with 95% confidence inter-
vals (CIs). P values<0.05 were considered statistically 
significant.
Results 
In total, there were 4203 ART cycles during the study 
period. A total of 990 eligible women and their hus-
bands underwent 927 ICSI and 63 ICSI with insemi-
nation (IVF/ICSI) cycles according to the inclusion 
criteria. The sampling procedure and distribution of 
the couples according to their BMI has been illustrated 
in (Fig.1).  According to BMI, of the 990 women par-
ticipants, there were 59 (6%) underweight, 357 (36%) 
with normal weight, 412 (41.6%) overweight, and 162 
(16.4%) obese participants. Of the 990 men evaluated, 
there were 18 (1.8%) underweight, 325 (32.7%) normal 
weight, 425 (43%) overweight, and 223 (22.5%) obese 
participants. 
The characteristics of the study population according to 
gender and BMI have been presented in (Table 1). The 
distribution of smoking in the males significantly differed 
among the BMI groups (P=0.006). The majority of fe-
males (n=786, 79.3%) had normal menses and ovulation. 
As expected, there were more anovulatory cases in the 
obese group than in the other groups (P=0.003). 
Anovulatory cases in the present study consisted of 
participants with PCOS (n=153, 75%) and age factor 
(over 37 to 39 years, n=51, 25%). 
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We separately evaluated the impact of female and male 
BMI on the live birth rate in ICSI. The results of the mul-
tilevel regression analysis according to female and male 
BMI has been shown in (Table 2). Among the ovulatory 
women, there was a significant difference between the 
BMI groups, with a 60% (95% CI: 0.11-0.83) decrease in 
the odds for live birth among overweight individuals and 
84% (95% CI: 0.02-0.99) decrease in the odds for live 
birth among obese individuals. Trend analysis showed a 
significant reduction of 9% (95% CI: 0.83-0.99) with each 
one unit increase in BMI (P=0.04). Among anovulatory 
women, the association between BMI and live births pre-
sented no clear tendencies, even though the ORs indicated 
lower probabilities for live births among overweight and 
obese anovulatory women. The 95% CIs were not sig-
nificant. Among anovulatory women, the trend analysis 
showed a significant reduction of 15% (95% CI: 0.72-
0.98) with every one unit increase in BMI (P=0.02). In 
both ovulatory and anovulatory underweight women, we 
observed a significant elevation in the odds of live births 
of 6.5 times (95% CI: 2.1-20.65) and 7.3 times (95% CI: 
0.99-55.1), but the CIs were too wide because of the low 
sample size. The results for men participants presented no 
significant relationship between BMI and live births. 
The comparison of the three groups of couples ac-
cording to BMI has been demonstrated in (Table 3). 
The overweight (P=0.01) and obese (P<0.001) couples 
were significantly older than normal weight couples. 
The results indicated that the three groups were com-
parable in terms of type, cause of infertility, number 
of previous ART cycles, and stimulation outcomes. 
There were no significant differences between the three 
groups in terms of fertilization, implantation, clinical 
pregnancy, multiple pregnancy, miscarriage, and live 
birth rates. 
Table 1: Basic characteristics of the studied population according to gender and body mass index
P valueObeseOverweight Normal weight UnderweightCharacteristics
n=162n=412n=357n=59
Women
<0.00132.2 ± 4.930.7 ± 4.830.0 ± 4.529.0 ± 3.9Age (Y)
0.00350 (30.9)84 (20.4)59 (16.5)11 (18.6)Anovulatory cases
 n=223 n=425 n=297n=45
Men 
0.08136.0 ± 6.435.0 ± 5.734.8 ± 5.635.1 ± 6.7Age (Y)
0.00669 (42.5)88 (21.3)58 (17.7)21 (35.5)Smoking cases
Data are presented as mean ± SD or n (%).
Table 2: Multilevel logistic regression analyses of the probability for live births following all ICSI or IVF/ICSI cycles according to gender and strati-
fied by BMI









































Femaleb BMI, (n=990 ICSI cycles among 990 women)
Ovulatory   
Underweight    
Normal weight    
Overweight    
Obese    
Trend 
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Underweight    
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Maleb BMI, (n=990 ICSI cycles among 990 men)   
Underweight    
Normal weight    
Overweight    
Obese   
Trend 
OR; Odds ratio, CI: Confidence interval, BMI; body mass index, IVF; In vitro fertilization, ICSI; Intra-cytoplasmic sperm injection, a; ORs with 95% CIs and P values from 
Wald tests, and b; Female analyses adjusted for age and duration of infertility. Male analyses adjusted for age, duration of infertility, and smoking status. 
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Table 3: Comparison of study population characteristics and cycle outcomes among three groups of couples according to BMI







0.018ᵃANOVA32.3 ± 4.730.5 ± 4.630.0 ± 4.7Female age (Y)
<0.001ᵇANOVA37.9 ± 5.435.1 ± 5.933.4 ± 4.7Male age (Y)
0.160ANOVA6.9 ± 3.46.1 ± 3.06.8 ± 3.6Female FSH  (IU/l)
0.986ANOVA4.6 ± 4.74.6 ± 4.14.7 ± 3.3Female LH  (IU/l)
0.646Kruskal-Wallis2.0 ± 1.42.4 ± 1.62.3 ± 1.7Female AMH (ng/ml)
0.658ANOVA2.3 ± 1.72.3 ± 1.92.1 ± 1.8Female TSH (mIU/l)
0.426Chi-squareType of infertility
37 (82.3)157 (88.7)107 (84.9)Primary 
8 (17.7)20 (11.3)19 (15.1)Secondary 
0.150Chi-squareCause of infertility
147 (83.1)32 (71.1)105 (83.3)Ovulatory 
30 (16.9)13 (28.9)21 (16.7)Anovulatory
0.577Chi-square131 (74)30 (66.7)89 (70.6)Male factor infertility cases
0.011cANOVA7.08 ± 4.76.39 ± 4.75.1 ± 3.4Infertility duration (Y)    
0.583ANOVA0.4 ± 0.90.3 ± 0.60.4 ± 0.9Number of previous ART cycles
0.664ANOVA10.9 ± 2.410.6 ± 2.110.7 ± 2.0Stimulation duration (days)  
0.176Kruskal-Wallis1839.9 ± 844.41810.1 ± 821.81932.6 ± 724.0Total amount of rFSH dose (IU)
0.582ANOVA2251.6 ± 1206.32087.9 ± 903.82086.1 ± 1005.4Total dose of used gonadotropins (IU)
0.564Chi-squareStimulation protocol
149 (84.2)40 (88.9)108 (85.7)Long agonist
28 (15.8)5 (11.1)18 (14.3)Antagonist
0.327ANOVA8.0 ± 3.528.3 ± 3.48.9 ± 4.3Total number of retrieved oocytes
0.974ANOVA5.0 ± 2.505.0 ± 2.75.1 ± 2.7Total number of embryos
0.978ANOVA2.4 ± 0.552.4 ± 0.52.4 ± 0.56Number of transferred embryo 
0.293ANOVA9.5 ± 1.99.9 ± 1.69.9 ± 1.4Endometrial thickness on transfer day (mm)
0.675Chi-squareQuality of transferred embryos (ET)*
32 (71.1)111 (62.7)82 (65.1)Good
2 (4.4)20 (11.3)11 (8.7)Fair
11 (24.4)46 (26)33 (26.2)Poor
0.523ANOVA0.78 ± 0.210.73 ± 0.240.74 ± 0.23Fertilization rate  
0.593ANOVA0.33 ± 0.160.31 ± 0.20.28 ± 0.173Implantation rate 
0.407Chi-square21 (87.5)68 (89.5)40 (78.4)Clinical pregnancy rate  
0.231Chi-square2 (8.3)6 (7.9)9 (17.6)Blighted ovum
0.936Chi-square1 (4.2)2 (2.6)2 (3.9)Ectopic pregnancy rate
0.664Chi-square5 (27.8)15 (27.3)7 (19.4)Multiple pregnancy rate
0.362Chi-square2 (10)9 (14.1)2 (5.3)Miscarriage rate
0.345Chi-square18 (90)55 (85.9)36 (94.7)Live birth rate 
Data are presented as mean ± SD or n (%). BMI; Body mass index, FSH; Follicle stimulating hormone, LH; Luteinizing hormone, AMH; Anti-Müllerian hormone, TSH; Thyroid stimulating 
hormone, ART; Assisted reproductive technology,  rFSH; Recombinant follicle-stimulating hormone, ANOVA: One-way analysis of variance, a; Obese couples vs. overweight couples 
(P=0.015), normal BMI vs. obese couples (P=0.040) according to Tukey’s test, b; Normal BMI vs. overweight couples (P=0.013), normal BMI vs. obese couples (P<0.001), overweight vs. 
obese couples (P=0.086) according to Tukey’s test, c; Normal BMI vs. overweight couples (P=0.032), normal BMI vs. obese couples (P=0.021) according to Tukey’s test, *; Good quality 
embryos-all ET were A, B, or AB, Fair-half of ET were good quality (AC, BC), Poor quality-all ET were C, D, or CD. 
The results of the multilevel logistic regression mod-
el for the detection of the predictive factors for the live 
birth rate showed that none of the included variables 
remained in the final model as significant factors. The 
results also revealed no significant association between 
the couples’ BMI and live births (Table 4). 
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Discussion
Previous studies separately evaluated the effects of both 
genders’ BMI on ART outcomes. The synergistic effects 
of obesity in couples were reported in limited studies (8, 
19). We have excluded the main confounding factors that 
affect live birth rates in order to accurately assess the in-
dependent effects of a couple’s obesity on ART outcomes. 
Our results revealed that a couple’s BMI had no effect on 
the outcomes of ICSI with fresh cleavage-stage embryo 
transfer cycles. 
Our results supported those published in 2013 by Pe-
tersen et al. (19), who reported that the combined in-
creased maternal and paternal BMI had no significant ef-
fect on live birth rate in ICSI cycles. However, the authors 
have presented the negative impacts of increased female 
and male BMI, both individually and combined, on live 
births in IVF cycles. In our institute, treatment cycles with 
only IVF are uncommon and the majority of treatment cy-
cles include ICSI or IVF/ICSI procedures. Therefore, we 
could not evaluate these subjects according to IVF cycles. 
The effects of female BMI on ART outcomes were eval-
uated in several studies. Our findings showed that among 
ovulatory women, BMI had a negative impact on live 
births. In anovulatory women, we observed a tendency 
for less odds of live births in the obese group, which was 
not statistically significant. Therefore, our results agreed 
with some recent studies where female BMI negatively 
impacted ART outcomes (8, 11, 13, 15, 20). On the other 
hand, previous studies indicated no negative effect of fe-
male BMI on ART outcomes (2, 12, 21-23). Petersen et 
al. (19) demonstrated that the female BMI had a nega-
tive impact on live birth rates in IVF cycles, but this was 
less clear in ICSI cycles. A prospective study conducted 
by Chavarro et al. (24) evaluated 170 women who under-
went 233 ART cycles and found an association between 
overweight and obese women with decreased live birth 
rates. Moragianni et al. (25), in a retrospective research 
of 4609 patients, found that obesity had significant nega-
tive effects on ART outcomes, with up to 68% lower odds 
of live births following the first ART cycle. Rittenberg et 
al. (15), in a meta-analysis of 47967 IVF/ICSI cycles, re-
ported that an increased female BMI was aligned with ad-
verse pregnancy outcomes in IVF/ICSI treatment cycles 
and this effect was observed in both overweight and obese 
women. Since the earlier investigations did not categorize 
their findings according to type of treatment cycle (IVF 
or ICSI ), a more adverse influence of increased BMI in 
IVF compared to ICSI might have been concealed and 
the intensity of the BMI impact on IVF/ICSI possibly re-
lied on the IVF and ICSI cycle distributions in the sample 
size (19). Although a number of multiparous women are 
obese, a negative association of obesity with women’s re-
productive health has been reported (26). Because of the 
conflicting results reported by studies, the mechanism ac-
tion of maternal obesity on IVF or IVF/ICSI outcomes 
remains unclear (27). Although a number of oocyte do-
nation studies have suggested negative effects of obesity 
on the endometrium (6, 28), others have not (2, 21, 29). 
Endocrine changes related to obesity such as hyperandro-
genism and insulin resistance as well as alterations in the 
local insulin-like growth factors (IGFs), cytokines, and 
leptin levels may play a major role in the adverse effects 
of an increased BMI on ART outcomes (4). According to 
previous studies (13), the mechanism of action of obesity 
in anovulatory cases, especially PCOS women, is differ-
ent and depends on the intensity of the endocrine changes. 
The influence of male BMI on ART outcomes has been 
less studied. The existing literature contains only 7 stud-
ies on this subject (1, 8, 11, 16, 17, 19, 30). The first study, 
published in 2011 by Bakos et al. (1), reported an asso-
ciation between high paternal BMI with significantly re-
duced clinical pregnancy and live birth rates after ART. 
Two recent studies presented that male BMI was asso-
ciated with a negative impact on clinical pregnancy and 
live birth rates after IVF, but not after ICSI. Additionally, 
the previous studies in this field reported that ICSI might 
overcome the negative impact of obesity on sperm-oo-
cyte interaction (16, 19). On the other hand, a prospec-
tive study conducted by Colaci et al. (17) evaluated 114 
couples who underwent 172 ICSI cycles and concluded 
that male obesity was associated with decreased odds 
for live births after ICSI. Our results indicated that the 
male BMI had no effect on live birth rates after ICSI. The 
deleterious effects of male obesity could be due to an al-
tered hormonal profile and decreased semen quality re-
lated to increased leptin and E2 levels, and disturbance in 
spermatogenesis (19, 31). However, a systematic review 
with meta-analysis found no evidence of an association 
between an increased BMI and semen parameters (32). 
A systematic review by Campbell et al. (33) in 2015 re-
ported that the rate of births per ART cycle was reduced 
by 35% in obese men. The salient weak point in the previ-
ous studies and our study was the use of BMI as a marker 
Table 4: Multilevel logistic regression analysis for detection of predictive factors for live birth after ICSI or IVF/ICSI cycles 
in the studied population
Live birth per ICSI cycleCombined BMI (kg/m2)





ICSI; Intracytoplasmic sperm injection, IVF; In vitro fertilization, BMI; Body mass index, OR; Odds ratio, and CI; Confidence interval. 
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of body fat in men. In view of these conflicting results, 
we suggest that prospective studies should evaluate the 
effects of male and female abdominal obesity on repro-
ductive parameters and ART outcomes via other anthro-
pometric measurements (waist and hip circumferences). 
Currently, the role of the male BMI in ART processes and 
outcomes is partly understood. Further investigations are 
needed to arrive at reliable conclusions (13). 
We analysed the couples and found no synergistic nega-
tive impact of increased female and male BMI on live 
births after ICSI cycles. This finding agreed with stud-
ies by Petersen et al. (19) and Schliep et al. (34). Some 
studies assessed the effects of combined male and female 
BMI on ART outcomes (4, 8, 10, 19). Petersen et al. (19) 
evaluated the effects of parental BMI on live birth rates 
after ART cycles. They reported that increased combined 
female and male BMI had a negative impact on live birth 
rates after IVF cycles; however, its effects in terms of ICSI 
were less clear. Schliep et al. performed a prospective as-
sessment of 721 couples and found no influence of the 
couples’ weight status on IVF outcomes (34). In contrast, 
a recent study by Wang and colleagues retrospectively in-
vestigated 12061 first fresh IVF/ICSI cycles and reported 
that female obesity exerted negative effects on live births 
after IVF; nonetheless, there was no evidence of a nega-
tive impact by the parental BMI on ICSI outcomes (4). 
In contrast, Umul et al. (10) found that couples’ obesity 
had a negative impact on clinical pregnancy rates and live 
birth rates following ICSI cycles. In the present study we 
meticulously analysed the characteristics of the couples in 
ICSI cycles and adjusted the impact of confounding fac-
tors on our results. Recent data have confirmed the find-
ings of those previous studies that reported no significant 
influence of the parental BMI on ICSI success. In view of 
the conflicting results, we suggest that more research be 
undertaken to shed sufficient light on this issue.
The present study has some limitations. There was no 
data about the specific hormonal profile and android or 
gynoid distribution of fat in anovulatory and ovulatory 
women, and no data about semen analysis parameters to 
compare among different BMI groups. We propose that 
these parameters should be considered in future studies.
Conclusion
Based on the current findings, an increased maternal 
BMI independently influenced negatively live birth rate 
after ICSI cycles, whereas increased paternal BMI sepa-
rately and in combination with maternal BMI did not 
show this affect.
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